Skip to main content
. 2022 Oct 26;66(11):e01028-22. doi: 10.1128/aac.01028-22

TABLE 6.

Summary of CYP alterations detected among non-wild-type Aspergillus spp. isolates in the 2020 international surveillance program

Country Organism MIC data (mg/liter)a
CYP alteration(s)
Manogepix Voriconazole Itraconazole Posaconazole CYP51A CYP51B
USA A. fumigatus 0.015 0.5 (WT) 2 (NWT) 0.25 (WT) I242V WT
USA A. fumigatus 0.06 1 (WT) 2 (NWT) 0.5 (WT) WT Q42L
USA A. fumigatus 0.015 0.5 (WT) 2 (NWT) 0.25 (WT) WT Q42L
USA A. fumigatus 0.03 0.5 (WT) 2 (NWT) 0.5 (WT) N248K WT
USA A. fumigatus 0.015 0.5 (WT) 2 (NWT) 0.5 (WT) F46Y, M172V, N248T, D255E, E427K WT
France A. fumigatus 0.06 1 (WT) 4 (NWT) 1 (NWT) WT Q42L
New Zealand A. fumigatus 0.03 8 (NWT) >8 (NWT) 8 (NWT) G138C WT
UK A. fumigatus 0.015 2 (NWT) 4 (NWT) 1 (NWT) L98H, TR34 WT
UK A. fumigatus 0.008 2 (NWT) 4 (NWT) 0.5 (WT) L98H, TR34 WT
UK A. fumigatus 0.008 2 (NWT) 8 (NWT) 1 (NWT) L98H, TR34 WT
USA A. fumigatus 0.015 0.5 (WT) 2 (NWT) 0.25 (WT) I242V WT
a

Categorical interpretations of non-wild type (NWT) and wild type (WT) are according to ECVs from CLSI document M57 (24). The ECV for posaconazole was 0.5 mg/liter.